Innovative Solutions for Critical Tissue Reconstruction

Using our proprietary technology platform for tissue engineering and manufacturing, Novadip is addressing the need for critical size bone and skin reconstruction in patients who currently have limited or no effective treatment options.

A product family based on a single technology

An innovative family of cell-based regeneration therapies. Novadip Biosciences pioneers the growth of 3-dimensional biologics based on adipose-derived stem cells (ASC), to regenerate hard and soft tissues. ASCs offer sizable advantages in regeneration medicine. The fatty tissue has demonstrated a much higher proportion of stem cells compared to the bone marrow, which is another reservoir

Our Achievements

Since 2013, Novadip Biosciences has been developing breakthrough innovations in cell-based therapies for hard and soft tissue. While our first mission was to treat patients with bone defects and bone diseases, our adipose stem cell-based technology now offers potential for further applications, including skin regeneration.

Market Application

Novadip Biosciences: a family of new generation, 3D therapies based on adipose stem cells, for hard and soft tissue reconstruction.   Market application for NVD-001: bone healing disorders and critical size bone defects with unmet medical needs. Bone healing disorders and critical size bone defects following degenerative conditions, trauma, infection, congenital deficiency or tumour resection